Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Acta Physiologica Sinica ; (6): 707-722, 2021.
Artigo em Chinês | WPRIM | ID: wpr-921274

RESUMO

Glucose and lipid metabolism is the most fundamental metabolic activity of higher organisms. This process is affected by both genetic polymorphisms and environmental factors. Excessive uptake and accumulation of lipids lead to obesity and disorder of glucose metabolic homeostasis characterized by insulin resistance and hyperglycemia, suggesting that the cross-regulation between lipid and glucose metabolism happens precisely at organ, cellular and molecular levels by known mechanisms. Adenine nucleotides and their metabolites have emerged as mediators in the mutual regulation of glucose and lipid metabolism. This review summarizes the roles of purinergic signaling induced by fatty acids in glucose metabolism and the development of type 2 diabetes.


Assuntos
Humanos , Nucleotídeos de Adenina , Diabetes Mellitus Tipo 2 , Glucose , Homeostase , Resistência à Insulina , Metabolismo dos Lipídeos
2.
Acta Pharmaceutica Sinica ; (12): 1152-1156, 2008.
Artigo em Chinês | WPRIM | ID: wpr-232626

RESUMO

The in vitro release behavior, in vivo biodistribution and antitumor activity of N-(2-hydroxypropyl) methacrylamide (HPMA) copolymer-5-fluorouracil conjugates (P-FU) were studied. The in vitro release behavior was evaluated by determining the amount of 5-fluorouracil (5-FU) released from P-FU in mice plasma at 37 degrees C. The in vivo biodistribution and therapeutic evaluation were investigated with Kunming mice bearing hepatoma 22 (H22). The in vitro half-life (t1/2) of P-FU in mice plasma was 32.4 h. It appeared that the circulation life time of the conjugates were 166 times longer than that of 5-FU. The AUC and t1/2 of P-FU in tumor were 3.3 times and 2.3 times more than those of 5-FU, respectively. Therapeutic evaluation also demonstrated that the treatment with P-FU displayed stronger inhibition of the tumor growth when compared with that of 5-FU (P < 0.05). HPMA copolymer is a potential carrier for 5-FU for effective treatment of cancer.


Assuntos
Animais , Feminino , Camundongos , Acrilamidas , Farmacocinética , Farmacologia , Antimetabólitos Antineoplásicos , Farmacocinética , Farmacologia , Área Sob a Curva , Linhagem Celular Tumoral , Portadores de Fármacos , Composição de Medicamentos , Fluoruracila , Farmacocinética , Farmacologia , Neoplasias Hepáticas Experimentais , Metabolismo , Patologia , Transplante de Neoplasias , Distribuição Aleatória , Distribuição Tecidual , Carga Tumoral
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA